
Cinven to invest in Medpace
European private equity firm Cinven has acquired a majority investment in Medpace for a total consideration of USD915m from CCMP Capital Advisors. Medpace is a global contract research organisation (CRO) business providing management services to the R&D departments of pharma, biotech and medical device clients to help plan and oversee




